Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs

Development of nontoxic, tumor-targetable, and potent in vivo RNA delivery systems remains an arduous challenge for clinical application of RNAi therapeutics. Herein, we report a versatile RNAi nanoplatform based on tumor-targeted and pH-responsive nanoformulas (NFs). The NF was engineered by combin...

Full description

Bibliographic Details
Main Authors: Choi, Ki Young, Silvestre, Oscar F., Huang, Xinglu, Min, Kyung Hyun, Howard, Gregory P., Hida, Naoki, Jin, Albert J., Carvajal, Nicole, Lee, Sang Wook, Hong, Jong-In, Chen, Xiaoyuan
Other Authors: Massachusetts Institute of Technology. Department of Chemical Engineering
Format: Article
Language:en_US
Published: American Chemical Society (ACS) 2015
Online Access:http://hdl.handle.net/1721.1/97479
https://orcid.org/0000-0002-8848-7559
_version_ 1811084215988518912
author Choi, Ki Young
Silvestre, Oscar F.
Huang, Xinglu
Min, Kyung Hyun
Howard, Gregory P.
Hida, Naoki
Jin, Albert J.
Carvajal, Nicole
Lee, Sang Wook
Hong, Jong-In
Chen, Xiaoyuan
author2 Massachusetts Institute of Technology. Department of Chemical Engineering
author_facet Massachusetts Institute of Technology. Department of Chemical Engineering
Choi, Ki Young
Silvestre, Oscar F.
Huang, Xinglu
Min, Kyung Hyun
Howard, Gregory P.
Hida, Naoki
Jin, Albert J.
Carvajal, Nicole
Lee, Sang Wook
Hong, Jong-In
Chen, Xiaoyuan
author_sort Choi, Ki Young
collection MIT
description Development of nontoxic, tumor-targetable, and potent in vivo RNA delivery systems remains an arduous challenge for clinical application of RNAi therapeutics. Herein, we report a versatile RNAi nanoplatform based on tumor-targeted and pH-responsive nanoformulas (NFs). The NF was engineered by combination of an artificial RNA receptor, Zn(II)-DPA, with a tumor-targetable and drug-loadable hyaluronic acid nanoparticle, which was further modified with a calcium phosphate (CaP) coating by in situ mineralization. The NF can encapsulate small-molecule drugs within its hydrophobic inner core and strongly secure various RNA molecules (siRNAs, miRNAs, and oligonucleotides) by utilizing Zn(II)-DPA and a robust CaP coating. We substantiated the versatility of the RNAi nanoplatform by demonstrating effective delivery of siRNA and miRNA for gene silencing or miRNA replacement into different human types of cancer cells in vitro and into tumor-bearing mice in vivo by intravenous administration. The therapeutic potential of NFs coloaded with an anticancer drug doxorubicin (Dox) and multidrug resistance 1 gene target siRNA (siMDR) was also demonstrated in this study. NFs loaded with Dox and siMDR could successfully sensitize drug-resistant OVCAR8/ADR cells to Dox and suppress OVCAR8/ADR tumor cell proliferation in vitro and tumor growth in vivo. This gene/drug delivery system appears to be a highly effective nonviral method to deliver chemo- and RNAi therapeutics into host cells.
first_indexed 2024-09-23T12:47:07Z
format Article
id mit-1721.1/97479
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T12:47:07Z
publishDate 2015
publisher American Chemical Society (ACS)
record_format dspace
spelling mit-1721.1/974792022-09-28T09:59:22Z Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs Choi, Ki Young Silvestre, Oscar F. Huang, Xinglu Min, Kyung Hyun Howard, Gregory P. Hida, Naoki Jin, Albert J. Carvajal, Nicole Lee, Sang Wook Hong, Jong-In Chen, Xiaoyuan Massachusetts Institute of Technology. Department of Chemical Engineering Koch Institute for Integrative Cancer Research at MIT Choi, Ki Young Jin, Albert J. Development of nontoxic, tumor-targetable, and potent in vivo RNA delivery systems remains an arduous challenge for clinical application of RNAi therapeutics. Herein, we report a versatile RNAi nanoplatform based on tumor-targeted and pH-responsive nanoformulas (NFs). The NF was engineered by combination of an artificial RNA receptor, Zn(II)-DPA, with a tumor-targetable and drug-loadable hyaluronic acid nanoparticle, which was further modified with a calcium phosphate (CaP) coating by in situ mineralization. The NF can encapsulate small-molecule drugs within its hydrophobic inner core and strongly secure various RNA molecules (siRNAs, miRNAs, and oligonucleotides) by utilizing Zn(II)-DPA and a robust CaP coating. We substantiated the versatility of the RNAi nanoplatform by demonstrating effective delivery of siRNA and miRNA for gene silencing or miRNA replacement into different human types of cancer cells in vitro and into tumor-bearing mice in vivo by intravenous administration. The therapeutic potential of NFs coloaded with an anticancer drug doxorubicin (Dox) and multidrug resistance 1 gene target siRNA (siMDR) was also demonstrated in this study. NFs loaded with Dox and siMDR could successfully sensitize drug-resistant OVCAR8/ADR cells to Dox and suppress OVCAR8/ADR tumor cell proliferation in vitro and tumor growth in vivo. This gene/drug delivery system appears to be a highly effective nonviral method to deliver chemo- and RNAi therapeutics into host cells. National Institute for Biomedical Imaging and Bioengineering (U.S.) National Institutes of Health (U.S.) AXA Research Fund (Postdoctoral Fellowship) National Research Foundation of Korea (Postdoctoral Fellowship 2013R1A6A3A03) National Research Foundation of Korea (Grant 2009-0080734) 2015-06-19T18:44:03Z 2015-06-19T18:44:03Z 2014-04 2014-01 Article http://purl.org/eprint/type/JournalArticle 1936-0851 1936-086X http://hdl.handle.net/1721.1/97479 Choi, Ki Young, Oscar F. Silvestre, Xinglu Huang, Kyung Hyun Min, Gregory P. Howard, Naoki Hida, Albert J. Jin, et al. “Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs.” ACS Nano 8, no. 5 (May 27, 2014): 4559–4570. © 2014 American Chemical Society https://orcid.org/0000-0002-8848-7559 en_US http://dx.doi.org/10.1021/nn500085k ACS Nano Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf American Chemical Society (ACS) American Chemical Society
spellingShingle Choi, Ki Young
Silvestre, Oscar F.
Huang, Xinglu
Min, Kyung Hyun
Howard, Gregory P.
Hida, Naoki
Jin, Albert J.
Carvajal, Nicole
Lee, Sang Wook
Hong, Jong-In
Chen, Xiaoyuan
Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
title Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
title_full Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
title_fullStr Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
title_full_unstemmed Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
title_short Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
title_sort versatile rna interference nanoplatform for systemic delivery of rnas
url http://hdl.handle.net/1721.1/97479
https://orcid.org/0000-0002-8848-7559
work_keys_str_mv AT choikiyoung versatilernainterferencenanoplatformforsystemicdeliveryofrnas
AT silvestreoscarf versatilernainterferencenanoplatformforsystemicdeliveryofrnas
AT huangxinglu versatilernainterferencenanoplatformforsystemicdeliveryofrnas
AT minkyunghyun versatilernainterferencenanoplatformforsystemicdeliveryofrnas
AT howardgregoryp versatilernainterferencenanoplatformforsystemicdeliveryofrnas
AT hidanaoki versatilernainterferencenanoplatformforsystemicdeliveryofrnas
AT jinalbertj versatilernainterferencenanoplatformforsystemicdeliveryofrnas
AT carvajalnicole versatilernainterferencenanoplatformforsystemicdeliveryofrnas
AT leesangwook versatilernainterferencenanoplatformforsystemicdeliveryofrnas
AT hongjongin versatilernainterferencenanoplatformforsystemicdeliveryofrnas
AT chenxiaoyuan versatilernainterferencenanoplatformforsystemicdeliveryofrnas